MADOPAR LIQ cpr 125 mg 100 pce
7680523770562
CH-52377
N04BA02
01.08.0.
1 / 3
google
Details
- Product number
- 5237702
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- levodopum 100.00 mg, benserazidum 25.00 mg ut benserazidi hydrochloridum, acidum citricum, amylum pregelificatum, cellulosum microcristallinum, magnesii stearas pro compresso.
Articles (1)
Madopar LIQ 125, Tabletten zur Herstellung einer Suspension zum Einnehmen
Tabletten zur Herstellung einer Suspension zum Einnehmen
100
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 31.65
Specialties list
Yes
Generic
No
SL addition date:
15/03/1994
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 52377
- Drug name
- Madopar LIQ, Tabletten zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- TABSU
- ATC Code
- N04BA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 24/02/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 01.08.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MADOPAR LIQ cpr 125 mg 100 pce
- Description (DE)
- MADOPAR LIQ Tabl 125 mg 100 Stk
- Market launch
- 24/02/1994
- Narcotic (BTM)
- No